This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stimpel, M Articles by Lohmann-Matthes, M L Search for Related Content PubMed PubMed Citation Articles by Stimpel, M Articles by Lohmann-Matthes, M L

 Previous Article  |  Next Article 

Infect Immun. 1984 December; 46(3): 845-849

Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea.

ABSTRACT

Purified polysaccharides (EPS) prepared from the plant Echinacea purpurea are shown to strongly activate macrophages. Macrophages activated with these substances develop pronounced extracellular cytotoxicity against tumor targets. The activation is brought about by EPS alone and is independent of any cooperative effect with lymphocytes. Also the production and secretion of oxygen radicals and interleukin 1 by macrophages is increased after activation with EPS. Cells of the macrophages lineage seem to be the main target for the action of these polysaccharides. EPS has no effect on T lymphocytes. B lymphocytes show a comparatively modest proliferation after incubation with E. purpurea EPS. Thus, these compounds, which are at least in tissue culture completely nontoxic, may be suited to activate in vivo cells of the macrophage system to cytotoxicity. They may therefore be of relevance in tumor and infectious systems.

This article has been cited by other articles:

• Koenig, K, Roehr, C C (2006). Does treatment with Echinacea purpurea effectively shorten the course of upper respiratory tract infections in children?. Arch. Dis. Child. 91: 535-537 [Full Text]  
• Miller, S. C. (2005). Echinacea: a Miracle Herb against Aging and Cancer? Evidence In vivo in Mice. Evid Based Complement Alternat Med 2: 309-314 [Abstract] [Full Text]  
• Lee, A. N., Werth, V. P. (2004). Activation of Autoimmunity Following Use of Immunostimulatory Herbal Supplements. Arch Dermatol 140: 723-727 [Abstract] [Full Text]  
• Cohen, H. A., Varsano, I., Kahan, E., Sarrell, E. M., Uziel, Y. (2004). Effectiveness of an Herbal Preparation Containing Echinacea, Propolis, and Vitamin C in Preventing Respiratory Tract Infections in Children: A Randomized, Double-blind, Placebo-Controlled, Multicenter Study. Arch Pediatr Adolesc Med 158: 217-221 [Abstract] [Full Text]  
• Taylor, J. A., Weber, W., Standish, L., Quinn, H., Goesling, J., McGann, M., Calabrese, C. (2003). Efficacy and Safety of Echinacea in Treating Upper Respiratory Tract Infections in Children: A Randomized Controlled Trial. JAMA 290: 2824-2830 [Abstract] [Full Text]  
• Block, K. I., Mead, M. N. (2003). Immune System Effects of Echinacea, Ginseng, and Astragalus: A Review. Integr Cancer Ther 2: 247-267 [Abstract]  
• Kocyigit, A., Gur, S., Gurel, M. S., Bulut, V., Ulukanligil, M. (2002). Antimonial Therapy Induces Circulating Proinflammatory Cytokines in Patients with Cutaneous Leishmaniasis. Infect. Immun. 70: 6589-6591 [Abstract] [Full Text]  
• Rininger, J. A., Kickner, S., Chigurupati, P., McLean, A., Franck, Z. (2000). Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cells. J. Leukoc. Biol. 68: 503-510 [Abstract] [Full Text]  
• Turner, R. B., Riker, D. K., Gangemi, J. D. (2000). Ineffectiveness of Echinacea for Prevention of Experimental Rhinovirus Colds. Antimicrob. Agents Chemother. 44: 1708-1709 [Abstract] [Full Text]  
• Miller, L. G. (1998). Herbal Medicinals: Selected Clinical Considerations Focusing on Known or Potential Drug-Herb Interactions. Arch Intern Med 158: 2200-2211 [Abstract] [Full Text]